Projection neurons from the central nucleus of the amygdala to the nucleus pontis oralis.
The present retrograde labeling study was designed to determine the presence and pattern of projections from individual subdivisions of the central nucleus of the amygdala (CNA) to the nucleus pontis oralis (NPO), which is a critical brainstem site involved in the generation and maintenance of active (REM) sleep. Projections from the CNA were labeled with the retrograde tracer cholera toxin B-subunit (CTB), which was injected, unilaterally, via microiontophoresis, into the NPO. Sections of the amygdala were immunostained in order to identify CTB-labeled CNA neurons and CNA neurons that contained CTB plus the vesicular glutamate transporter 2 (VGLUT2), which is a marker for glutamatergic neurons. Histological analyses revealed that retrogradely labeled neurons that project to the NPO were localized, ipsilaterally, within the medial, lateral, and capsular subdivisions of the CNA. In addition, a substantial proportion (24%) of all retrogradely labeled CNA neurons also exhibited VGLUT2 immunoreactivity. The present study demonstrates that glutamatergic neurons, which are present within various subdivisions of the CNA, project directly to the NPO. These data lend credence to the hypothesis that NPO neurons that are involved in the control of active sleep are activated by glutamatergic projections from the amygdala.
VA Greater Los Angeles Healthcare System, Los Angeles, California, USA. sfung@websciences.org
Simon J
SJ
Fung
Mingchu
M
Xi
Jianhua
J
Zhang
Pablo
P
Torterolo
Sharon
S
Sampogna
Francisco R
FR
Morales
Michael H
MH
Chase
D000679:Amygdala / Q000166:cytology* / Q000502:physiology; D000818:Animals; D002772:Cholera Toxin / Q000378:metabolism; D005260:Female; D008297:Male; D009434:Neural Pathways / Q000502:physiology; D009474:Neurons / Q000502:physiology*; D011149:Pons / Q000502:physiology*; D013552:Swine; D050599:Vesicular Glutamate Transport Protein 2 / Q000378:metabolism
D050599:Vesicular Glutamate Transport Protein 2; D002772:Cholera Toxin
Neuroscience. 1987 Mar;20(3):961-89
2439943
Brain Res. 2001 Jun 8;903(1-2):257-62
11382413
Sleep. 2009 Dec;32(12):1593-601
20041595
Neuroscience. 1989;30(2):405-21
2568603
J Comp Neurol. 1978 Mar 15;178(2):225-54
627625
Physiol Behav. 1975 Jul;15(1):17-9
172925
Endocrinology. 2006 Aug;147(8):3818-25
16675529
Brain Res. 1984 Jun 15;303(2):337-57
6204716
J Comp Neurol. 2008 Feb 20;506(6):943-59
18085591
Brain Res. 2007 Nov 7;1179:42-50
17888415
Brain Res Bull. 1988 Nov;21(5):829-33
2464424
Sleep Med. 2007 Jun;8(4):302-30
17468046
Nature. 2006 Jun 1;441(7093):589-94
16688184
Exp Neurol. 2009 Apr;216(2):290-4
19124019
Arch Ital Biol. 2004 Jul;142(4):379-96
15493543
Neuroscience. 2005;136(4):1073-81
16226839
Brain Res. 1990 Nov 26;534(1-2):209-24
1705851
Physiol Rev. 2003 Jul;83(3):803-34
12843409
Brain Res. 2002 Nov 29;956(2):276-84
12445696
Neuroreport. 1996 Jan 31;7(2):577-80
8730833
J Physiol Paris. 2006 Nov-Dec;100(5-6):271-83
17689057
J Neurosci. 2001 Nov 15;21(22):RC181
11698619
Brain Res. 2009 May 1;1268:76-87
19269278
Neurochem Int. 2006 Jun;48(8):753-61
16481069
Exp Brain Res. 1993;93(2):231-41
8491264
Brain Res. 2004 Jul 30;1016(1):129-34
15234261
J Neurosci. 1981 Nov;1(11):1242-59
6171630
Sleep. 2005 Aug 1;28(8):923-30
16218075
Cell Tissue Res. 2005 Apr;320(1):33-50
15714284
Brain Res. 2005 Apr 11;1041(1):29-37
15804497
Eur J Neurosci. 2003 Sep;18(6):1627-39
14511341
Nature. 1996 Sep 12;383(6596):163-6
8774879
Arch Sci Biol (Bologna). 1977 Jan-Dec;61(1-4):1-37
400095
Neuron. 2001 Aug 2;31(2):247-60
11502256
Annu Rev Neurosci. 2000;23:155-84
10845062
Brain Res. 1987 Jun 30;414(2):245-61
3620930
J Neurophysiol. 1999 Oct;82(4):2015-9
10515993
Exp Brain Res. 1978 Aug 15;32(4):529-47
689127
Mol Psychiatry. 1997 May;2(3):195-6
9152982
J Neurosci. 1999 Nov 1;19(21):9508-18
10531453
J Comp Neurol. 1999 Oct 11;413(1):113-28
10464374
Neuroreport. 1996 Nov 25;7(18):3069-72
9116242
Physiol Behav. 2005 Nov 15;86(4):415-26
16137725
J Neuroendocrinol. 2006 Apr;18(4):253-65
16503920